XML 71 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Revenue Generated in Product Category for Years Indicated (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Segment Reporting Information [Line Items]      
Revenues $ 71,348 $ 65,206 $ 55,312
Product Category | U.S. | Revenue      
Segment Reporting Information [Line Items]      
Revenues $ 69,336 $ 63,406 $ 53,447
Percentage of Revenues 100.00% 100.00% 100.00%
Product Category | U.S. | Revenue | NeuroStar Advanced Therapy System      
Segment Reporting Information [Line Items]      
Revenues $ 16,460 $ 16,575 $ 9,760
Percentage of Revenues 24.00% 26.00% 18.00%
Product Category | U.S. | Revenue | Treatment Sessions      
Segment Reporting Information [Line Items]      
Revenues $ 50,896 $ 45,077 $ 41,933
Percentage of Revenues 73.00% 71.00% 78.00%
Product Category | U.S. | Revenue | Other      
Segment Reporting Information [Line Items]      
Revenues $ 1,980 $ 1,754 $ 1,754
Percentage of Revenues 3.00% 3.00% 4.00%
Product Category | International | Revenue      
Segment Reporting Information [Line Items]      
Revenues $ 2,012 $ 1,800 $ 1,865
Percentage of Revenues 100.00% 100.00% 100.00%
Product Category | International | Revenue | NeuroStar Advanced Therapy System      
Segment Reporting Information [Line Items]      
Revenues $ 629 $ 811 $ 1,108
Percentage of Revenues 31.00% 45.00% 59.00%
Product Category | International | Revenue | Treatment Sessions      
Segment Reporting Information [Line Items]      
Revenues $ 754 $ 354 $ 264
Percentage of Revenues 38.00% 20.00% 14.00%
Product Category | International | Revenue | Other      
Segment Reporting Information [Line Items]      
Revenues $ 629 $ 635 $ 493
Percentage of Revenues 31.00% 35.00% 27.00%